PMC:7558914 / 13729-14030
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 89-96 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T12 | 89-96 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 333 | 89-96 | Chemical | denotes | heparin | MESH:D006493 |
| 338 | 15-23 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 339 | 139-149 | Disease | denotes | thrombosis | MESH:D013927 |
| 340 | 158-166 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 341 | 220-242 | Disease | denotes | venous thromboembolism | MESH:D054556 |
| 342 | 246-275 | Disease | denotes | acute ischemic artery disease | MESH:D014715 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T24 | 184-209 | Phenotype | denotes | cytokine release syndrome | http://purl.obolibrary.org/obo/HP_0033041 |
| T25 | 227-242 | Phenotype | denotes | thromboembolism | http://purl.obolibrary.org/obo/HP_0001907 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T94 | 0-301 | Sentence | denotes | In 8 of the 15 COVID-19 protocols (53.3%), the dose of prophylactic low-molecular-weight heparin was increased if there was a high risk of thrombosis (severe COVID-19 with evidence of cytokine release syndrome, previous venous thromboembolism or acute ischemic artery disease, or D-dimer >3000 ng/mL). |